The "Elevate" by MAPS Podcast

The Learning Objectives for this podcast are to understand the scope and requirements of the main privacy laws and regulations, covering data types and processing activities including collection, usage, data retention, subjects’ rights and much more.

This podcast also considers the risks and practical application of the regulations in the conduct of various Medical Affairs activities.

This podcast looks at the identification and mitigation of risks in four examples of activities at the Medical/Commercial interface with the intent of strengthening your understanding of how to conduct these activities in a compliant manner. The examples include Medical/Commercial field interactions, patient support programs, advice seeking, and use of artificial intelligence.

From chatbots and content generation to insights mining and decision support, GenAI is moving from buzzword to backbone. In this "Elevate" episode, our hosts Jennifer Riggins & Steve Casey speak to a panel of experts on the frontlines of GenAI implementation to share their hard-won insights.

In this podcast episode, our experts dive into the importance of storytelling in scientific communication, emphasizing the need to balance creativity with accuracy and personalize content for different audiences.

This podcast will provide an overview of results of a poster presented at MAPS Americas in 2025. The title of the poster was "One Team, One Voice: The Impact of Centralized Medical Content Development" and includes results from a survey that was conducted to better understand Medical Affairs (MA) professionals’ strategies for medical content development, utilizing centralized versus decentralized medical content creation, and assess the adoption of structured authoring and AI-enabled solutions to improve scalability, consistency and efficiency in medical content development.

When is the right time to bring your medical information system in-house? What needs to happen once you get there? In this podcast, we dive into scPharmaceuticals’ experience and discuss the milestones that signal a shift. Hear about the case for change, navigating the transition, and the crucial role technology plays in enabling long-term success.

AI offers tremendous benefits but creates new challenges for licensing and research integrity that medical publishers must address. In this MAPS podcast episode, we will discuss the opportunities and challenges of AI in scientific publishing and considerations for medical education.

Expedited publications are essential for rapidly disseminating research findings and accelerating drug approval processes, particularly during public health emergencies. This approach encompasses efficient manuscript development, expedited reviews, and prioritized submissions to scientific journals, ultimately ensuring that critical data swiftly reaches the healthcare community. The urgency for timely information is underscored by examples such as COVID-19, where rapid dissemination played a significant role in updating treatment protocols and informing vaccine practices. However, the podcast also addresses significant challenges faced, including regulatory hurdles, resource constraints, and the risk of compromising research integrity due to pressures for rapid output. Stakeholders such as pharmaceutical companies, regulatory agencies, healthcare providers, and patients can benefit from expedited publications, yet they must navigate the fine balance between speed and quality. By exploring methodologies for successful expedited publishing, including pre-planning, stakeholder engagement, and strategic communication, this podcast highlights the importance of a robust framework for overcoming hurdles and fostering advancements in pharmaceutical research and public health.

The Times Higher Education recently reported that Bluesky has overtaken X in hosting posts related to new academic research. And yet many Medical Affairs teams aren't equipped to maximize the potential of this emerging resources. Here we speak with Mike Taylor, Head of Data Insights, at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about the uses of Bluesky in comparison with exiting social media platforms, and how Medical Affairs can leverage this resource for insights, KOL identification/mapping, data dissemination and more. 

Believe it or not, the field of Kardashian studies can inform the ways Medical Affair professionals identify and understand influencers and influence in the space of science communications. Here we talk with Mike Taylor, Head of Data Insights at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about making sense of what is otherwise certainly nonsense.